Allergan to Shut Irish Plant,
Shift to Costa Rica
DUBLIN (Reuters) - U.S. medical
device maker Allergan will close
its breast implant factory in
the east of Ireland and shift
production to Costa Rica,
resulting in the loss of 360
Irish jobs, it said on
Wednesday.
Production at the plant in
Arklow, south of Dublin, will be
phased out over the next two
years, with restructuring and
transition costs of between $60
million and $65 million
expected, Allergan said in a
statement.
"For economic and operational
reasons, Allergan will
consolidate the manufacturing of
its breast implant products to
the company's state-of-the-art
facility in Costa Rica,"
Allergan, which has 7,500
employees globally, said.
Allergan, which also makes Botox
anti-wrinkle injections, said it
would keep its pharmaceutical
plant in the western Irish town
of Westport, which employs 750
people and its European shared
services centre in Dublin, with
70 staff. (Reporting by Andras
Gergely; Editing by Paul
Bolding)
|
